Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.43 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.43 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.43 |
| ▸ | CSNK2A3 | Q8NEV1 | 2/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.40 |
| ▸ | MEN1 | O00255 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | BLM | P54132 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.40 |
| ▸ | USP2 | O75604 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.40 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10013659 | 0.92 | KDM4E (0.43) | CSNK2A2CSNK2BCSNK2A1CSNK2A3KMT2A | |
| SCHEMBL10013644 | 0.84 | CSNK2A2 (0.50) | CSNK2A2CSNK2BCSNK2A1CSNK2A3CYP19A1 | |
| SCHEMBL10013636 | 0.83 | CSNK2A2 (0.49) | CSNK2A2CSNK2BCSNK2A1CSNK2A3CYP19A1 | |
| SCHEMBL10351964 | 0.81 | CYP19A1 (0.57) | CSNK2A2CSNK2BCSNK2A1CSNK2A3CYP19A1 | |
| SCHEMBL16807521 | 0.81 | HPGDS (0.41) | CSNK2A2CSNK2BCSNK2A1CSNK2A3CYP19A1 | |
| SCHEMBL13350306 | 0.80 | CSNK2A2 (0.46) | CSNK2A2CSNK2BCSNK2A1CSNK2A3CYP19A1 | |
| SCHEMBL10013651 | 0.80 | CSNK2A2 (0.46) | CSNK2A2CSNK2BCSNK2A1CSNK2A3CYP19A1 | |
| SCHEMBL10013650 | 0.80 | CSNK2A2 (0.46) | CSNK2A2CSNK2BCSNK2A1CSNK2A3CYP19A1 | |
| SCHEMBL13350278 | 0.80 | CSNK2A2 (0.46) | CSNK2A2CSNK2BCSNK2A1CSNK2A3CYP19A1 | |
| SCHEMBL10013634 | 0.80 | CSNK2A2 (0.46) | CSNK2A2CSNK2BCSNK2A1CSNK2A3CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9709557-B2 | Anthraquinone based near IR emitting compounds and uses thereof | Life Technologies Corporation (US) | 2017-07-18 | — | — | US | disclosed |
| US-9709557-B2 | Anthraquinone based near IR emitting compounds and uses thereof | Life Technologies Corporation (US) | 2017-07-18 | — | — | US | disclosed |
| US-20150168383-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation | 2015-06-18 | — | — | US | disclosed |
| US-20150168383-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation | 2015-06-18 | — | — | US | disclosed |
| US-8999965-B2 | Anthraquinone based near IR emitting compounds and uses thereof | Life Technologies Corporation (US) | 2015-04-07 | — | — | US | disclosed |
| US-8999965-B2 | Anthraquinone based near IR emitting compounds and uses thereof | Life Technologies Corporation (US) | 2015-04-07 | — | — | US | disclosed |
| US-20120028249-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120028249-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation (US) | 2012-02-02 | — | — | US | disclosed |
| WO-2010062499-A2 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation (US) | 2010-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120028249-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | ANTXR2, AAAS, IK | CSNK2A2 3068/4885CSNK2B 2721/4885CSNK2A1 3190/4885 |
| US-20150168383-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | ANTXR2, AAAS, IK | CSNK2A2 3068/4885CSNK2B 2721/4885CSNK2A1 3190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.